Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 6 days ago

Dolby Laboratories, Inc.: MORGAN STANLEY amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Morgan Stanley amended its Schedule 13G filing on Dolby Laboratories, disclosing a revised passive stake in the company under SEC accession 0000895421-26-000310. The filing updates the bank's previously reported ownership position in the audio and imaging technology firm. Schedule 13G amendments are typically filed when a passive investor's stake crosses or adjusts past the 5% reporting threshold, though the filing did not specify the exact percentage change. The revision matters because it signals a shift in a major institutional holder's exposure to Dolby. Investors will watch for further 13G or 13D filings to confirm whether Morgan Stanley's position continues to change.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Morgan Stanley (MS), Dolby Laboratories, Inc.

A linked name opens that asset's sentiment page.